Goals of the Symposium

The San Antonio Breast Cancer Symposium® is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease to an international audience of academic and private physicians and researchers.

The scientific program consists of formal lectures by experts in clinical, translational, and basic research; selected slide and poster presentations; forums; and case discussions. The official language of the symposium is English. Simultaneous translation is not provided.

Target Audience

This international Symposium is directed primarily toward academic and private physicians and researchers involved in breast cancer in medical, surgical, gynecologic, and radiation oncology, as well as patient advocates and other appropriate health care professionals. SABCS expects over 10,000 attendees from more than 102 countries will attend in 2025.

Symposium Location

The Symposium is held at the Henry B. Gonzalez Convention Center, 900 E. Market Street, San Antonio, Texas. Attendees also have the opportunity to access the virtual meeting.

Executive Committee

  • Carlos L. Arteaga, MD
    UT Southwestern, Harold C. Simmons Cancer Center, Dallas, Texas, Symposium Co-director
  • Virginia G. Kaklamani, MD
    UT Health San Antonio Mays Cancer Center, San Antonio, Texas, Symposium Co-director
  • Kate Lathrop, MD
    UT Health San Antonio Mays Cancer Center, San Antonio, Texas, Symposium Program Director
  • Carissia Calvo-Strube, MD
    University of Texas Health Science Center San Antonio, San Antonio, Texas
  • Margaret Foti, PhD, MD (hc)
    American Association for Cancer Research, Philadelphia, Pennsylvania
  • Charles M. Perou, PhD
    University of North Carolina, Chapel Hill, North Carolina
  • Hope Rugo, MD
    University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California
  • Alana Welm, PhD
    University of Utah Huntsman Comprehensive Cancer Center, Salt Lake City, Utah
  • Lei Zheng, MD, PhD
    University of Texas Health San Antonio Mays Cancer Center, San Antonio, Texas

Program Planning Committee

  • Carole Baas, PhD
    Advocate, Physical Sciences in Oncology Network at the (USA) National Cancer Institute, Southlake, Texas
  • Vernal Branch
    Independent Research Patient Advocate, Richmond, Virginia
  • David Cescon, MD, PhD
    Princess Margaret Cancer Centre, Toronto, Canada
  • Fergus Couch, PhD
    Mayo Clinic, Rochester, Minnesota
  • Christina Curtis, PhD, MSc
    Stanford University, Stanford, California
  • Leif Ellisen, MD, PhD
    Harvard University, Cambridge, Massachusetts
  • Heide Ford, PhD
    University of Colorado, Denver, Colorado
  • William Gradishar, MD
    Northwestern University Feinberg School of Medicine, Chicago, Illinois
  • Fred Howard, MD
    University of Chicago, Chicago, Illinois
  • Mary Jimenez
    Alamo Breast Cancer Foundation, San Antonio, Texas
  • Seema Khan, MD
    Northwestern University Feinberg School of Medicine, Chicago, Illinois
  • Tari A. King, MD, FACS
    Brigham and Women’s Hospital, Boston, Massachusetts
  • Marleen Kok
    Netherlands Cancer Institute, Amsterdam, Netherlands
  • Julia Maues
    GRASP, Washington, D.C.
  • Ben Park, MD, PhD
    Vanderbilt University School of Medicine, Nashville, Tennessee
  • Pedram Razavi, MD, PhD
    Memorial Sloan Kettering Cancer Center, New York, New York
  • Sonya Reid, MD, MPH
    Vanderbilt-Ingram Cancer Center, Nashville, Tennessee
  • David Rimm, MD, PhD
    Yale School of Medicine, New Haven, Connecticut
  • Tara Sanft, MD
    Yale School of Medicine, New Haven, Connecticut
  • Christos Sotiriou, MD, PhD
    Jules Bordet Institute, Anderlecht, Belgium
  • Jonathan Strauss, MD
    Northwestern University Feinberg School of Medicine, Chicago, Illinois
  • Antoinette Tan, MD, MHSc, FACP
    Atrium Health Levine Cancer Institute, Charlotte, North Carolina
  • Alexandra Thomas, MD, FACP
    Duke Cancer Institute, Durham, North Carolina
  • Adrienne Waks, MD
    Dana-Farber Cancer Institute, Boston, Massachusetts
  • Zhi-Ming Shao, MD, PhD
    Fudan University Cancer Institute, Shanghai, China
  • Qing Zhang, PhD
    UT Southwestern Medical Center, Dallas, Texas